Abstract

BackgroundLipid accumulation product (LAP) has been advocated as a simple clinical indicator of metabolic syndrome (MS). However, no studies have evaluated the accuracy of LAP in predicting MS in Taiwanese adults. The aim of our investigation was to use LAP to predict MS in Taiwanese adults.MethodsTaiwanese adults aged 50 years and over (n = 513) were recruited from a physical examination center at a regional hospital in southern Taiwan. MS was defined according to the MS criteria for Taiwanese people. LAP was calculated as (waist circumference [cm] − 65) × (triglyceride concentration [mM]) for men, and (waist circumference [cm] − 58) × (triglyceride concentration [mM]) for women. Simple logistic regression and receiver-operating characteristic (ROC) analyses were conducted.ResultsThe prevalence of MS was 19.5 and 21.5% for males and females, respectively. LAP showed the highest prediction accuracy among adiposity measures with an area under the ROC curve (AUC) of 0.901. This was significantly higher than the adiposity measure of waist-to-height ratio (AUC = 0.813).ConclusionsLAP was a simple and accurate predictor of MS in Taiwanese people aged 50 years and over. LAP had significantly higher predictability than other adiposity measures tested.

Highlights

  • Lipid accumulation product (LAP) has been advocated as a simple clinical indicator of metabolic syndrome (MS)

  • Around 20.5% of subjects were classified as having MS according to Metabolic syndrome criteria for Taiwanese (MS-TW) criteria, with no

  • Regarding the diagnostic accuracy for MS-TW, LAP showed the highest area under the ROC curve (AUC) value (0.90; 95% CI, 0.87–0.93), followed by waist-to-height ratio (0.81; 95% CI, 0.77–0.86)

Read more

Summary

Introduction

Lipid accumulation product (LAP) has been advocated as a simple clinical indicator of metabolic syndrome (MS). According to MS-TW, the diagnosis of MS is made when at least three of the following five risk determinants are present: waist circumference ≥ 90 cm in men and ≥ 80 cm in women; blood pressure > 130/85 mmHg or patient is taking antihypertensive medications; high-density lipoprotein cholesterol (HDL-C) < 0.9 mM in men and < 1.03 mM in women; fasting plasma glucose ≥ 5.6 mM or patient is undergoing regular treatment for diabetes mellitus; and triglyceride level ≥ 1.70 mM It would be useful if a simpler index is available for easy diagnosis of individuals at risk of MS in clinical settings

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call